We are live on
!
Find out more
Cardiff Oncology
CRDF
CRDF
60 hedge funds and large institutions have $10.7M invested in Cardiff Oncology in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 9 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
30% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 10
3% more funds holding
Funds holding: 58 → 60 (+2)
1.06% less ownership
Funds ownership: 18.29% → 17.23% (-1.1%)
12% less capital invested
Capital invested by funds: $12.2M → $10.7M (-$1.48M)
36% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 14
93% less call options, than puts
Call options by funds: $5K | Put options by funds: $75K
Holders
60
Holders Change
+2
Holders Change %
+3.45%
% of All Funds
0.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
9
Reduced
14
Closed
10
Calls
$5K
Puts
$75K
Net Calls
-$70K
Net Calls Change
-$117K
Top Buyers
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$336K |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$141K |
| 3 |
Renaissance Technologies
New York
|
+$98.8K |
| 4 |
Two Sigma Investments
New York
|
+$33.4K |
| 5 |
CC
Callan Capital
La Jolla,
California
|
+$19.5K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$279K |
| 2 |
Morgan Stanley
New York
|
-$137K |
| 3 |
Millennium Management
New York
|
-$84.5K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$60.5K |
| 5 |
CL
CSS LLC
Chicago,
Illinois
|
-$55K |
